Learn to trade in these market conditions - Click here Just Released!
Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter and Email Stock Watch Alerts.
GUYANA GOLD CORPORATION (OTC: GYGC | Quote | Chart | News | PowerRating) "Up 10.87% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/GYGC.php
Company Profile: http://www.otcpicks.com/guyana-gold/guyana-gold.htm
Guyana Gold Corporation is a junior mineral exploration company that specializes in identifying, acquiring and developing precious and base metal properties as well as assessing whether certain claims possess exploitable commercial and precious mineral reserves. The Company's objective is to develop a balanced global portfolio of early-to-advanced stage projects. Guyana is currently focused on gold projects in the Caribbean. The Company's key mineral project is located in the region of Port Kaituma, in which the Company holds a 50% interest as part of its joint venture with Octagon Mining Corp. The main interests along the Guyana Shield are gold, diamond and bauxite and, recently, semi-precious stones.
GYGC News:
June 30 - Guyana Gold Corp. to Cancel 114,250,000 of Its Common Shares of the Company Stock
Guyana's Cancellation Will Reduce the Outstanding Shares from 165,038,947 to 50,788,947
Guyana Gold Corp. (OTC: GYGC | Quote | Chart | News | PowerRating) announced that a decision has been made to cancel 114,250,000 common shares. This cancellation will reduce the company's outstanding shares from 165,038,947 to 50,788,947, which represents approximately 70% of the issued and outstanding shares.
Eduard Aronov, President of Guyana Gold Corp., commented that, "This action to reduce the company's issued and outstanding shares shows the great commitment level management has for its shareholders and to the future growth of the company." Additionally he noted, "I am confident that our future revenue stream will continue to produce results that our shareholders have come to expect. These things, combined with other exciting events we see in the very near future, should make the next couple of years very exciting for Guyana Gold Corp."
Further details will be released as they become available.
CARBON SCIENCES INCORPORATED (OTCBB: CABN)
Detailed Quote: www.otcpicks.com/quotes/CABN.php
Company Profile: www.otcpicks.com/carbon-sciences/carbon-sciences-2.htm
Carbon Sciences, Inc. focuses on developing GreenCarbon technology to convert carbon dioxide into a form that would not contribute to global warming. Its GreenCarbon technology is targeted at coal-fired electrical power plants and fuel production plants. The company was founded in 2006 as Zingerang, Inc. and changed its name to Carbon Sciences, Inc. in April 2007. Carbon Sciences, Inc. is based in Santa Barbara, California.
CABN News:
June 30 - Carbon Sciences Announces Joint Research Agreement With University and Its Research Team
Research Team From Finland Is Considered Among the World's Leaders in Carbon Mineralization Research
Carbon Sciences Inc. (OTCBB: CABN), the developer of a breakthrough technology to transform harmful carbon dioxide (CO2) into high value, earth-friendly products, announced that it has signed a joint research agreement with Abo University, Finland.
The research team led by Professor Ron Zevenhoven at Abo University is considered among the world's leaders in carbon transformation research. Carbon transformation, technically referred to as carbon mineralization, is a process in which CO2 is combined with rock minerals to produce a solid carbonate. Due to the unique geology of Finland, underground sequestration of CO2 is not an economically viable option. Therefore, an important option for CO2 mitigation in Finland is carbon transformation.
Derek McLeish, the company's CEO, commented, "Carbon Sciences is aligning with various international strategic partners. With the completion of this agreement, we'll be working with the world's premier researchers in CO2 carbon transformation."
"We are pleased to be researching carbon mineralization technologies with Carbon Sciences," stated Professor Ron Zevenhoven of Abo University. "Our research associates have studied and worked with many promising approaches to permanently capturing CO2 in the last decade. We are delighted to be working with Carbon Sciences, a visionary company in the industry."
Professor Zevenhoven, formerly of Helsinki University, has been at the forefront of this research for many years. Geological sequestration or underground storage is one of the proposed solutions for mitigating CO2 emissions. However, in many instances it is simply not feasible, geographically or economically, to bury CO2 underground. Long term environmental and human risks and their associated costs argue instead for other technical solutions. Carbon Sciences' technology transforms CO2, using a carbon mineralization process, into high value products used in everyday life.
FRONTIER ENERGY CORPORATION (OTC: FRGY | Quote | Chart | News | PowerRating) "Up 50.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/FRGY.php
Frontier Energy Corp. engages in the acquisition, exploration, development, and operation of oil and gas reserves primarily in the United States. The company was founded in 1986 and is based in North Las Vegas, Nevada.
FRGY News:
June 27 - Frontier Energy Corp. Signs Letter of Intent for Purchase of Assets of Cancen Oil Processors
Frontier Energy Corporation (OTC: FRGY | Quote | Chart | News | PowerRating) ("Frontier" or the "Company") announced it has signed a letter of intent for the purchase of all assets and on-going business of Cancen Oil Processors, Inc. ("Cancen") (www.cancenoil.com), a private company. Cancen's assets include a refinery, multiple disposal wells and an existing operating business with experienced staff.
Frontier CEO Bob Genesi comments, "All parties are very excited about what this potential purchase could mean for Frontier and for Cancen. Discussions have been swift and only minor details remain. We hope to announce a completion of this purchase in the near term."
The Letter of Intent includes provisions whereby the two parties will use their best efforts to move forward to execute and deliver a definitive purchase and sale agreement within a short period of time. Additional information will be forthcoming as it becomes available.
LABOPHARM INCORPORATED (NASDAQ: DDSS | Quote | Chart | News | PowerRating) "Up 44.61% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/DDSS.php
Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. Visit www.labopharm.com for more information.
DDSS News:
June 30 - Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
Company Expects to Submit Complete Response by End of Week
Labopharm Inc. (NASDAQ: DDSS | Quote | Chart | News | PowerRating) (TSX: DDS) announced that the Company has received a response from the U.S. Food and Drug Administration (FDA) regarding its most recent appeal of the decision in the Agency's Approvable Letter for its once-daily tramadol formulation through the Formal Dispute Resolution process.
Procedurally, Dr. Douglas Throckmorton, M.D., the FDA's Deputy Director, Center for Drug Evaluation and Research, agreed with Dr. Jenkins, M.D., Director for the Office of New Drugs, Center for Drug Evaluation and Research and denied the appeal. However, he suggested a regulatory path forward. Dr. Throckmorton has suggested that the Company submit the analysis put forward by Dr. Jenkins in his letter of earlier this year. In the response, the FDA has concluded that a positive finding using this analysis could provide the needed assurance to support the efficacy of Labopharm's once-daily tramadol. Following resolution of any issues with labeling, such a finding would lead to the approval of the product.
The Company expects to submit the complete response before the end of the week and the FDA has agreed to conduct its review of the response in a timely basis.
"We are encouraged by the Agency's request to formally submit the data analysis that Dr. Jenkins suggested we undertake and believe that this is a positive step towards regulatory approval in the U.S.," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "The request follows a meeting with the FDA, as well as constructive discussions over the past two months. We continue to believe that the comprehensive data generated by our global clinical trial program demonstrates the efficacy and safety of our once-daily tramadol formulation and that we have met the statutory standards for approval of our formulation."
Labopharm has completed the statistical analysis of data suggested by Dr. Jenkins and believes that the findings confirm the conclusions of efficacy of its once-daily tramadol formulation.
ABOUT LABOPHARM'S ONCE-DAILY TRAMADOL PRODUCT
Labopharm's once-daily tramadol product is based on the Company's proprietary Contramid technology, which provides a dual matrix delivery system allowing both rapid and sustained drug release that maintains blood levels within the therapeutic range providing a full 24 hours of pain relief. The Company believes that maintaining drug concentrations within the therapeutic range has the advantage of fewer and less severe side effects while maintaining efficacy. Under its global commercialization program, Labopharm's once-daily tramadol product has been launched in 11 countries, including the five largest markets in Europe and Canada and is approved in 19 other countries. Including those countries in which its product has been launched, Labopharm has licensing and distributions in place for more than 50 markets globally.
BUZZ TECHNOLOGIES INCORPORATED (OTC: BZTG | Quote | Chart | News | PowerRating) "Up 18.92% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BZTG.php
Buzz Technologies, Inc. is a convergent media company with operations ranging from infrastructure development to online retail.
BZTG News:
June 27 - Independent Web Traffic Data Released on Buzz
Buzz Technologies, Inc. (OTC: BZTG | Quote | Chart | News | PowerRating) has released independent Web Traffic Data from Truehits. The Data reflects the rapid uptake of the site amongst users in Asia.
04/2008
Page Views: 226,733 (+41.69%) Thai Users: 32,698 (+94.77%) Sessions: 75,238 (+128.26%)
05/2008
Page Views: 2,208,797 (+874.18%) Thai Users: 351,965 (+976.41%) Sessions: 1,552,147 (+1962.98%)
06/2008
Page Views: 10,765,687 (+387.40%) Thai Users: 980,096 (+178.46%) Sessions: 4,277,642 (+175.60%)
ABOUT TRUEHITS
Truehits (www.truehits.net) has been developed and managed by Government Information Technology Services (GITS) of Thailand. Truehits currently provides independent web traffic analysis as well as website rankings. Unlike other estimation sites (Google, Alexa etc.), Truehits collects live web traffic data through a Java script code attached to the website and the traffic will be accurately measured on Truehits servers allowing the raw data to be used for traffic information, analysis and comparison.
Alexa Rankings Today show www.12buzz.com as the 5,359th most popular site in the world on June 22, 742nd most popular in China with strong showings in Thailand, Taiwan, Hong Kong and Japan as well.
ABOUT THE ALEXA TRAFFIC RANKINGS
Alexa (www.alexa.com) computes traffic rankings by analyzing the Web usage of millions of Alexa Toolbar users and data obtained from other, diverse traffic data sources.
ABOUT OTCPICKS.COM
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.
Release of Liability:Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com is being compensated eight thousand dollars by a third party for GYGC advertising and promotional services. OTCPicks is receiving nine thousand dollars directly from the company for CABN advertising and promotion services. For a complete list of disclosures go to http://www.otcpicks.com/disclosure-details.htm. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.
The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.
Third Party Web Sites and Information:
OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
CONTACT: Brian Dean, Publisher, OTCPicks.com Tel: +1 972 546 3740 e-mail: publisher@otcpicks.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
